MedTrace Logo

Metabolic and Epigenetic Impact of FAAH Inhibitors and OEA

NCT07127445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2026-03-10

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether a dietary supplement can affect gene expression and serum protein markers in healthy volunteers. The main questions it aims to answer are:

1. Does the supplement affect gene expression and protein markers as measured in blood?
2. How does daily ingestion of the supplement affect anthropometric measurements, including body mass index, waist circumference, blood pressure, and heart rate?
3. How does daily ingestion of the supplement affect subjective health parameters?
4. Is ingesting the supplement daily safe, as measured by laboratory tests and adverse events?

The supplement is made with oleoylethanolamide (OEA), ginger extract, and lavender essential oil.

Participants will:

* Take one supplement capsule in the morning and one in the evening every day for 12 weeks
* Attend three study visits in which they provide blood and urine samples, and undergo anthropometric measurements
* Complete surveys and subjective health assessments

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

OEA supplement

The supplement contains OEA, ginger extract, and lavender essential oil as its active ingredients.

Sponsors & Collaborators

  • Nicole Stevens, PhD

    lead INDUSTRY

Principal Investigators

  • Nicole Stevens, PhD · doTERRA International

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-08-19
Primary Completion
2025-12-19
Completion
2025-12-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07127445 on ClinicalTrials.gov